Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-11-063802
Filing Date
2011-03-11
Accepted
2011-03-11 15:07:25
Documents
15
Period of Report
2011-05-12

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT dpre14a.htm PRE 14A 1372983
2 GRAPHIC g155616g08d42.jpg GRAPHIC 29605
3 GRAPHIC g155616g20a01.jpg GRAPHIC 13611
4 GRAPHIC g155616g24j70.jpg GRAPHIC 25442
5 GRAPHIC g155616g26l78.jpg GRAPHIC 19438
6 GRAPHIC g155616g45i01.jpg GRAPHIC 22600
7 GRAPHIC g155616g46r97.jpg GRAPHIC 189437
8 GRAPHIC g155616g60a91.jpg GRAPHIC 113863
9 GRAPHIC g155616g60u09.jpg GRAPHIC 9103
10 GRAPHIC g155616g79k66.jpg GRAPHIC 23596
11 GRAPHIC g155616g85p01.jpg GRAPHIC 18564
12 GRAPHIC g155616g86x05.jpg GRAPHIC 30111
13 GRAPHIC g155616g87i03.jpg GRAPHIC 11709
14 GRAPHIC g155616g91n65.jpg GRAPHIC 26863
15 GRAPHIC g155616g93m90.jpg GRAPHIC 23721
  Complete submission text file 0001193125-11-063802.txt   2144409
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19731 | Film No.: 11681721
SIC: 2836 Biological Products, (No Diagnostic Substances)